TrialPharmacoEconomics2019

A Q-TWiST Analysis Comparing Nivolumab and Therapy of Investigator's Choice in Patients with Recurrent/Metastatic Platinum-Refractory Squamous Cell Carcinoma of the Head and Neck.

Kim Cocks et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.